The first point-of-care test for detecting hepatitis C antibodies in unmodified blood samples has been approved by the US Food and Drug Administration (FDA).

OraSure Technologies’ OraQuick identifies hepatitis C antibodies in venous whole-blood specimens and can deliver results within 20 minutes.

More than four million people in the US are or have been infected with hepatitis C.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData